Search

everythinglearnresearchcommunity

for

Search:↓

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

A unique case showed a rare combination of two types of lichen planus on the face.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.